BioXcel Therapeutics (BTAI) Shares Issued (2017 - 2026)

BioXcel Therapeutics' Shares Issued history runs 10 years deep, the most recent figure standing at $1037.0 for Q1 2026.

• On a quarterly basis, Shares Issued fell 99.12% year-over-year to $1037.0 in Q1 2026; TTM through Mar 2026 was $1037.0, a 99.12% decrease from a year earlier, with the FY2025 full-year figure at $352000.0, up 13.18% from the prior year.
• Shares Issued retreated to $1037.0 in Q1 2026 per BTAI's latest filing, from $352000.0 in the prior quarter.
• Across five years, Shares Issued topped out at $4.9 million in Q4 2022 and bottomed at $560.0 in Q3 2023.
• The 5-year median for Shares Issued is $352000.0 (2025), against an average of $1.3 million.
• Across the five-year window, Shares Issued sank 99.99% in 2023 and jumped 65792.86% in 2024, its largest moves.
• Year by year, Shares Issued stood at $4.9 million in 2022, then plunged by 93.63% to $311000.0 in 2023, then changed by 0.0% to $311000.0 in 2024, then gained by 13.18% to $352000.0 in 2025, then tumbled by 99.71% to $1037.0 in 2026.
• Per Business Quant, the three latest BTAI Shares Issued figures stand at $1037.0 (Q1 2026), $352000.0 (Q4 2025), and $106000.0 (Q3 2025).